Company: STAA
Filing Date: 2025-09-24
Form Type: DEFC14A
Source: 0001213900-25-090869
Chunk: 0

Company: STAAR SURGICAL CO
Filing Date: 2025-09-24
Form: DEFC14A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
(Amendment No. )</div>

| Filed by the Registrant                    | ☐ |
| Filed by a party other than the Registrant | ☒ |

Check the appropriate box:

| ☐ | Preliminary     
 Proxy Statement |

| ☐ | Confidential,                                                     
 for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |

| ☒ | Definitive Proxy Statement |

| ☐ | Definitive Additional Materials |

| ☐ | Soliciting Material Pursuant to §240.14a-12 |

<div align='center'>STAAR Surgical Company

(Name of Registrant as Specified
In Its Charter)

Broadwood Partners, L.P.

Broadwood Capital, Inc.

Neal C. Bradsher

Richard T. LeBuhn

Natalie R. Capasso

Raymond A. Myers

Jason J. Martin

(Name of Person(s) Filing Proxy Statement if other
than the Registrant)</div>

Payment of Filing Fee (Check all boxes that
apply):

| ☒ | No           
 fee required |

| ☐ | Fee paid previously with preliminary materials |

| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |

<div align='center'>STAAR SURGICAL COMPANY STOCKHOLDERS:

WE NEED YOUR HELP TO PROTECT THE VALUE OF YOUR INVESTMENT
BY VOTING “ AGAINST” THE PROPOSED MERGER.

BROADWOOD PARTNERS, L.P.

September 24, 2025</div>

Dear Fellow Stockholder:

The
attached Proxy Statement and the enclosed GREENProxy Card are being furnished to you,
the stockholders of STAAR Surgical Company, a Delaware corporation (the “Company”), in connection with the solicitation of
proxies by Broadwood Partners, L.P. for use at the special meeting of stockholders of the Company (including any adjournments, postponements,
reschedulings or continuations thereof, the “Special Meeting”), relating to the proposed acquisition of the Company (the
“Proposed Merger”) by Alcon Research, LLC, a Delaware limited liability